Water conservation protocols still are underway today due to a City of Houston water main break on Feb. 27. Due to the city-wide water supply disruption, our operations are impacted at the Texas Medical Center, West Houston and Memorial City locations.
MD Anderson has implemented the following emergency response measures:
All non-emergent patient care activities in the Texas Medical Center, West Houston and Memorial City...
A study at The University of Texas MD Anderson Cancer Center discovered a novel therapeutic vulnerability for patients who have tumors caused...
Comprehensive profiling of tumor samples taken from patients with osteosarcoma shows that multiple factors contribute to the traditionally...
The University of Texas MD Anderson Cancer Center today announced a strategic research collaboration with Denali Therapeutics Inc. to develop novel therapies for Alzheimer’s and other neurodegenerative diseases. Through this agreement, Denali will collaborate with researchers in the Neurodegeneration Consortium (NDC) at MD Anderson to investigate four therapeutic targets, with the goal of advancing novel small-molecule product candidates...
The University of Texas MD Anderson Cancer Center today was awarded more than $20 million from the Cancer Prevention and Research Institute...
The University of Texas MD Anderson Cancer Center today announced the Houston Dash will join the institution's efforts toward one goal...
Small cell lung cancer (SCLC) accounts for 14% of all lung cancers and is often rapidly resistant to chemotherapy, resulting in poor clinical...
Loss of an important tumor-suppressing gene allows head and neck cancer to spin off signals to nearby nerves, changing their function and...
According to results from a Phase I/IIa trial at The University of Texas MD Anderson Cancer Center, treatment with cord blood-derived chimeric...
A study led by The University of Texas MD Anderson Cancer Center furthered understanding about mitochondria, the cell components known as...